Cerevance: Clinical Trials

1 trial sponsored by Cerevance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Cerevance: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
CVN424 75 mg, CVN424 150 mg, Placebo - Parkinson Disease
Phase 3Active not recruitingCerevance3302024-09-202026-04-17

Conditions studied

Parkinson Disease (1)

Countries

Australia (1)  ·  Czechia (1)  ·  France (1)  ·  Italy (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)